Mercator Medical S.A. - Asset Resilience Ratio

Latest as of September 2025: 7.15%

Mercator Medical S.A. (MRC) has an Asset Resilience Ratio of 7.15% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

zł71.81 Million
≈ $19.76 Million USD Cash + Short-term Investments

Total Assets

zł1.00 Billion
≈ $276.27 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2020–2024)

This chart shows how Mercator Medical S.A.'s Asset Resilience Ratio has changed over time. Check Mercator Medical S.A. strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Mercator Medical S.A.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see MRC market cap overview.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents zł0.00 0%
Short-term Investments zł71.81 Million 7.15%
Total Liquid Assets zł71.81 Million 7.15%

Asset Resilience Insights

  • Limited Liquidity: Mercator Medical S.A. maintains only 7.15% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Mercator Medical S.A. Industry Peers by Asset Resilience Ratio

Compare Mercator Medical S.A.'s asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Blue Sail Medical Co Ltd
SHE:002382
Medical Instruments & Supplies 4.32%
Austco Healthcare Ltd
AU:AHC
Medical Instruments & Supplies 15.90%
Ocumetics Technology Corp
V:OTC
Medical Instruments & Supplies 0.00%
Ansell Ltd
AU:ANN
Medical Instruments & Supplies 7.53%
Nanosonics Ltd
AU:NAN
Medical Instruments & Supplies 46.84%
Trajan Group Holdings Ltd
AU:TRJ
Medical Instruments & Supplies 0.29%
Osteopore Ltd
AU:OSX
Medical Instruments & Supplies 22.60%
Nyxoah
BR:NYXH
Medical Instruments & Supplies 12.40%

Annual Asset Resilience Ratio for Mercator Medical S.A. (2020–2024)

The table below shows the annual Asset Resilience Ratio data for Mercator Medical S.A..

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 12.17% zł126.96 Million
≈ $34.94 Million
zł1.04 Billion
≈ $287.17 Million
+0.82pp
2023-12-31 11.35% zł109.53 Million
≈ $30.14 Million
zł965.23 Million
≈ $265.64 Million
-6.98pp
2022-12-31 18.32% zł198.46 Million
≈ $54.62 Million
zł1.08 Billion
≈ $298.08 Million
+3.14pp
2021-12-31 15.19% zł195.69 Million
≈ $53.86 Million
zł1.29 Billion
≈ $354.62 Million
+3.76pp
2020-12-31 11.43% zł147.32 Million
≈ $40.54 Million
zł1.29 Billion
≈ $354.84 Million
--
pp = percentage points

About Mercator Medical S.A.

WAR:MRC Poland Medical Instruments & Supplies
Market Cap
$130.62 Million
zł474.62 Million PLN
Market Cap Rank
#18155 Global
#127 in Poland
Share Price
zł51.90
Change (1 day)
-0.19%
52-Week Range
zł37.45 - zł62.00
All Time High
zł680.00
About

Mercator Medical S.A., together with its subsidiaries, manufactures and distributes disposable medical gloves, dressings, and non-woven fabric products in Poland, the Czech Republic, Ukraine, France, Hungary, Italy, Romania, Germany, rest of Europe, and Thailand. The company offers surgical and protective, sterile examination and protective, and household gloves; glove brackets; and household and… Read more